University Hospital, Bordeaux
Clinical trials sponsored by University Hospital, Bordeaux, explained in plain language.
-
New cement mends broken backs without heat damage
Disease control TerminatedThis study tested a special bone cement (MCPC) that is similar to natural bone and can be absorbed over time, allowing new bone to grow. It was given to 4 adults aged 18-65 with recent severe spine fractures. The cement was injected during a low-invasive surgery to fill the broke…
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
Heart drug may tame baby blood vessel growth
Disease control TerminatedThis study tested the drug propranolol in infants under 4 months old with capillary hemangiomas (non-dangerous blood vessel growths). The goal was to see if early treatment could shrink the growths. The study was stopped early and only 14 infants took part, so results are limited…
Phase: PHASE2, PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC
-
Bladder cancer drug combo shows promise in early trial
Disease control TerminatedThis study tested whether adding the immunotherapy drug avelumab to standard chemotherapy (gemcitabine and cisplatin) could improve outcomes for people with advanced bladder cancer that had spread. The trial enrolled 65 patients and measured how many responded to treatment and ho…
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC
-
Early-Study safety check on lenalidomide after transplant for myeloma
Disease control TerminatedThis early-phase study looked at whether the drug lenalidomide is safe to give after a stem cell transplant for multiple myeloma that has come back. It included 13 adults aged 18 to 65 whose cancer had responded to previous treatment. The goal was to see how many people had serio…
Phase: PHASE1 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 08, 2026 13:10 UTC
-
Experimental immune therapy for rare anemia shows early promise but trial halted
Disease control TerminatedThis early-stage trial tested whether low doses of interleukin-2 (IL-2) could help people with active warm autoimmune hemolytic anemia that did not respond to standard steroids. The goal was to increase a type of regulatory immune cell to control the disease. Only 2 participants …
Phase: PHASE1, PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 05, 2026 12:05 UTC
-
New scan seeks inflamed plaques after stroke
Diagnosis TerminatedThis study tested a new imaging method to detect inflammation in fatty plaques that cause strokes. It involved 3 men who had a recent stroke and were scheduled for surgery to remove a plaque in their neck artery. The goal was to see if a special PET scan tracer could highlight in…
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 10, 2026 13:29 UTC
-
Corn-Filled hope: could this veggie shield your eyes from blindness?
Prevention TerminatedThis study looked at whether eating corn with high levels of zeaxanthin (a natural pigment) could boost the eye's macular pigment, which may help prevent age-related macular degeneration (AMD), a leading cause of blindness. Nine healthy adults aged 20-35 ate the corn for 10 weeks…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Prevention
Last updated Jun 16, 2026 12:49 UTC
-
Nasal spray could speed pain relief for sickle cell emergencies
Symptom relief TerminatedThis study tested a nasal spray painkiller (sufentanil) for adults having a sickle cell pain crisis. The goal was to see if it relieved severe pain faster than the standard gas treatment (EMONO), before both groups received morphine. The trial was stopped early, so results are li…
Phase: PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 15, 2026 19:04 UTC
-
New combo therapy aims to curb food cravings in obesity
Symptom relief TerminatedThis study tested whether adding a special program that targets thinking skills, emotional control, and addictive eating behaviors to standard obesity treatment could help reduce food cravings and improve weight management. The program included group therapy sessions over 10 week…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 12, 2026 12:07 UTC
-
Vitamin c for pneumonia in seniors: study halted after just 9 patients
Symptom relief TerminatedThis study looked at whether giving vitamin C to hospitalized adults aged 75 and older with pneumonia could improve their breathing and daily function. Only 9 people took part before the study was stopped early. The goal was to see if vitamin C, which supports the immune system, …
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 08, 2026 13:08 UTC
-
Scientists gather COVID-19 samples to unlock virus secrets
Knowledge-focused TerminatedThis study aimed to collect and store biological samples (blood, respiratory, stool, urine) from 615 people with or without COVID-19 symptoms, including patients and caregivers at Bordeaux University Hospital. The goal was to build a resource for future research on the virus and …
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 16, 2026 21:14 UTC
-
MRI vs. CT: a safer way to track cystic fibrosis lung health?
Knowledge-focused TerminatedThis study looked at whether MRI scans can detect changes in the lungs of people with cystic fibrosis as well as CT scans do. CT scans use radiation, so finding a reliable alternative like MRI could mean safer monitoring over time. The study included 212 patients aged 8 and older…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:48 UTC
-
Smart soles could revolutionize walking tests for nerve disease patients
Knowledge-focused TerminatedThis study tested special shoe insoles with pressure sensors to see if they can accurately measure walking speed and step patterns in people with CIDP, a nerve condition that causes walking difficulties. Researchers compared the insoles to a standard electronic walkway. The goal …
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:08 UTC